250 related articles for article (PubMed ID: 32300972)
21. Adverse events in medication treatment-naïve children with attention-deficit/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylate.
Wigal SB; Wong AA; Jun A; Stehli A; Steinberg-Epstein R; Lerner MA
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):149-56. PubMed ID: 22372513
[TBL] [Abstract][Full Text] [Related]
22. [New-onset trichotillomania during treatment with stimulant drugs. About two pediatric clinical cases].
Fernández Manso B; Villora Morcillo N; Taboas Pereira MA; Elipe Maldonado C
Arch Argent Pediatr; 2020 Feb; 118(1):e61-e62. PubMed ID: 31984712
[TBL] [Abstract][Full Text] [Related]
23. α2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder.
Harstad E; Shults J; Barbaresi W; Bax A; Cacia J; Deavenport-Saman A; Friedman S; LaRosa A; Loe IM; Mittal S; Tulio S; Vanderbilt D; Blum NJ
JAMA; 2021 May; 325(20):2067-2075. PubMed ID: 33946100
[TBL] [Abstract][Full Text] [Related]
24. Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.
Brams M; Weisler R; Findling RL; Gasior M; Hamdani M; Ferreira-Cornwell MC; Squires L
J Clin Psychiatry; 2012 Jul; 73(7):977-83. PubMed ID: 22780921
[TBL] [Abstract][Full Text] [Related]
25. Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate?
Wigal SB; Jun A; Wong AA; Stehli A; Steinberg-Epstein R; Lerner MA
Postgrad Med; 2010 Sep; 122(5):27-34. PubMed ID: 20861585
[TBL] [Abstract][Full Text] [Related]
26. Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Banaschewski T; Johnson M; Nagy P; Otero IH; Soutullo CA; Yan B; Zuddas A; Coghill DR
CNS Drugs; 2018 May; 32(5):455-467. PubMed ID: 29790103
[TBL] [Abstract][Full Text] [Related]
27. Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder.
Blader JC; Pliszka SR; Kafantaris V; Foley CA; Crowell JA; Carlson GA; Sauder CL; Margulies DM; Sinha C; Sverd J; Matthews TL; Bailey BY; Daviss WB
J Am Acad Child Adolesc Psychiatry; 2013 Dec; 52(12):1281-93. PubMed ID: 24290461
[TBL] [Abstract][Full Text] [Related]
28. The Effects of Methylphenidate Treatment on Child Growth in Thai Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Koonrungsesomboon K; Koonrungsesomboon N
J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):189-197. PubMed ID: 31841645
[No Abstract] [Full Text] [Related]
29. Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe.
Coghill DR; Banaschewski T; Nagy P; Otero IH; Soutullo C; Yan B; Caballero B; Zuddas A
CNS Drugs; 2017 Jul; 31(7):625-638. PubMed ID: 28667569
[TBL] [Abstract][Full Text] [Related]
30. Examining the heterogeneity of treatment patterns in attention deficit hyperactivity disorder among children and adolescents in the Texas Medicaid population: modeling suboptimal treatment response.
Grebla R; Setyawan J; Park C; Richards KM; Nwokeji ED; Pawaskar M; Haim Erder M; Lawson KA
J Med Econ; 2019 Aug; 22(8):788-797. PubMed ID: 30983465
[No Abstract] [Full Text] [Related]
31. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
Moungnoi P; Maipang P
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
[TBL] [Abstract][Full Text] [Related]
32. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.
Efron D; Jarman F; Barker M
Pediatrics; 1997 Oct; 100(4):662-6. PubMed ID: 9310521
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Methylphenidate Safety and Maximum-Dose Titration Rationale in Attention-Deficit/Hyperactivity Disorder: A Meta-analysis.
Ching C; Eslick GD; Poulton AS
JAMA Pediatr; 2019 Jul; 173(7):630-639. PubMed ID: 31135892
[TBL] [Abstract][Full Text] [Related]
34. Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults.
Setyawan J; Hodgkins P; Guérin A; Gauthier G; Cloutier M; Wu E; Erder MH
J Med Econ; 2013 Oct; 16(10):1203-15. PubMed ID: 23937642
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
Stuhec M; Munda B; Svab V; Locatelli I
J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
[TBL] [Abstract][Full Text] [Related]
36. Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design.
Coghill DR; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson CS; Civil R; Dauphin M; Higgins N; Lyne A; Gasior M; Squires LA
J Am Acad Child Adolesc Psychiatry; 2014 Jun; 53(6):647-657.e1. PubMed ID: 24839883
[TBL] [Abstract][Full Text] [Related]
37. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
Varley CK; Vincent J; Varley P; Calderon R
Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
[TBL] [Abstract][Full Text] [Related]
38. EEG differences between good and poor responders to methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder.
Clarke AR; Barry RJ; McCarthy R; Selikowitz M
Clin Neurophysiol; 2002 Feb; 113(2):194-205. PubMed ID: 11856625
[TBL] [Abstract][Full Text] [Related]
39. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
40. Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
Ramtvedt BE; Aabech HS; Sundet K
J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):130-9. PubMed ID: 24666268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
